IGF2BP3 recognizes m6A to regulate histone-to-protamine replacement during mouse sperm development
Post-meiotic development of spermatids is under the control of a sophisticated RNA metabolic network, wherein the N6-methyladenosine (m<sup>6</sup>A) modification of mRNA, and proteins that bind to it, exert crucial functions in regulating sperm development from spermatogonia to spermatocytes. However, which m<sup>6</sup>A recognition proteins are involved in male post-meiotic spermiogenesis, and via which regulatory mechanisms, remains largely unknown. Here, we uncover the involvement of the m<sup>6</sup>A reader protein IGF2BP3 in the regulation of post-meiotic spermatid development. Genetic ablation of Igf2bp3 results in spermatogenesis defects, leading to male sub-fertility or even infertility. Mechanistically, IGF2BP3 loss-of-function leads to the excessive translation of its target RNAs associated with histone-to-protamine replacement, particularly Dot1l and Hdac11. IGF2BP3 translationally represses these targets through its m<sup>6</sup>A-binding property and through its interaction with its binding partner YBX2. Sperm developmental defects of IGF2BP3 knockout mouse can be rescued by siRNAs targeting Dot1l and Hdac11. Collectively, our findings define the essential role of IGF2BP3-dependent regulation of protein biosynthesis in histone-to-protamine replacement during spermiogenesis, helping to understand the functions of m<sup>6</sup>A RNA modification in sperm development and male fertility.
Authors
- Shaofang Ren (ORCID: https://orcid.org/0000-0001-8253-3166)
- Pisin Chen (ORCID: https://orcid.org/0000-0001-5251-7210)
- Jiexiang Zhao (ORCID: https://orcid.org/0000-0001-7429-5153)
- Zhou Yi-chun
- Chunmei Jing (ORCID: https://orcid.org/0009-0005-9930-3582)
- Haojie Yang (ORCID: https://orcid.org/0000-0002-8633-2713)
- Gang Chang (ORCID: https://orcid.org/0000-0002-0654-2762)
- Zhenyi Huang (ORCID: https://orcid.org/0000-0002-2676-9198)
- Liwei Ke (ORCID: https://orcid.org/0009-0002-7583-8783)
- Jun Liu (ORCID: https://orcid.org/0000-0002-2498-9963)
- Mei Wang (ORCID: https://orcid.org/0000-0002-4390-2018)
- Yuhan Chen (ORCID: https://orcid.org/0000-0002-2950-2675)
- Yi Zheng (ORCID: https://orcid.org/0000-0003-2630-9703)
- Dazhuang Wang (ORCID: https://orcid.org/0000-0002-5404-9032)
- Yunfan Xiang
Institutions
- Shenzhen University (CN)
- Peking University (CN)
- Zhujiang Hospital (CN)
- Center for Life Sciences (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- The EMBO Journal
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1038/s44318-025-00659-y
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China